Core Insights - Afya Limited reported strong financial results for Q4 and FY 2025, achieving significant growth in net income, adjusted EBITDA, and revenue, reflecting the robustness of its business model and operational execution [1] Financial Highlights - Q4 2025 net income increased by 13.7% YoY to R$175.4 million, while adjusted net income rose by 6.3% YoY to R$205.7 million, with basic EPS growth of 14.9% [1] - FY 2025 net income reached R$768.4 million, an 18.4% increase YoY, and adjusted net income was R$901.7 million, up 9.9% YoY, with basic EPS growth of 18.7% [1] - Q4 2025 revenue grew by 7.5% YoY to R$913.0 million, and FY 2025 revenue increased by 11.9% YoY to R$3,697.3 million [1] Adjusted EBITDA and Margins - Q4 2025 adjusted EBITDA rose by 6.1% YoY to R$388.5 million, with an adjusted EBITDA margin of 42.6%, a decrease of 50 bps YoY [1] - FY 2025 adjusted EBITDA increased by 15.4% YoY to R$1,680.3 million, with an adjusted EBITDA margin of 45.4%, an increase of 130 bps YoY [1] User Growth and Ecosystem - Afya's ecosystem reached approximately 301,000 users, with a significant increase in the number of continuing education students by 8.9% and a 9.4% growth in B2P revenue for medical practice solutions [1] - The company aims to strengthen its position as a leading medical education provider in Brazil, focusing on expanding its audience and enhancing digital products [1] Capital Allocation and Shareholder Returns - Afya's strong cash generation allowed for a record free cash flow of R$1,056 million and a solid cash position of R$1,125.4 million as of December 31, 2025 [1] - The Board of Directors approved a new share repurchase program for up to 4,000,000 Class A common shares and declared a cash dividend of R$307.4 million, representing 40% of the consolidated net income for 2025 [1] 2026 Guidance - For FY 2026, Afya expects revenue to range between R$3,950 million and R$4,100 million, and adjusted EBITDA to be between R$1,700 million and R$1,800 million, excluding any acquisitions [1]